Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It will get really ugly if they don't release the results tomorrow or on friday.
60/1 RS is tomorrow.This will have a large dump.May pick-up in a week or two,depending on management.Good luck and good trading.
The amount of noobs, talking about companies and reverse split like every situation is the same... Djeez
You can not dilute shares, that were not approved by shareholders.
As of now, the shelf is as good as empty, and they didn't ask for additional shares in the DEF14A file.
So, at the shareholders meeting June 21, they will not ask to authorize more shares. Not so difficult to understand though
Which shares are they going to dump? All authorized shares were used, and they asked 0 shares to be approved on the shareholders meeting end of June
I see exactly what you mean.
The trial 3 results is the key
Be honest, I'm out and will jump back in at times. Words of thought, most post splits, PPS will tank. Regardless, the company will dump shares. Let's assume that the trial 3 results is positive that rocks the PPS to, lets say $30 post r/s, would they rather dump 10m shares at $30 or at pre R/S $0.20. Of course the $30. Is it a bad thing for us investors? No, we gain what's is in the market for us. Do the company really cares about us investors and want to walk us through the commentary and hold our hands crossing the river? Absolutely not. But for the trial 3 results, In my opinion, I'm leaning toward a positive data. I could be wrong.
Good luck to all. My heart saden to those that suffocates under the water. May god bless you all.
I am anxious to see if the trial III results get released shortly after the split.
It all depends on ho far down they pull this. As of this pre-market 8am est it would roughly $7.80 per share. Most R/S I've been in are 1000's to 1 so you end up with a couple share that you can never do anything with because the price tanks. I think it all hinges on the P3 results, 60:1 isn't a bad split, if the share price goes up after due to positive news I, for once, could potentially have a positive outcome. So I tend to agree, as far as R/S go, this could be the exception but we will have to wait and see.
when computers became readily accessible back in the early 2000s, when market trading by individuals exploded into massive activity,
this so called 'market' started to become one big corrupted ponzi scheme. And the REAL REASON for the market called FINANCIALs, FUNDAMENTALS went out the window.
Hype, Lies, Hope started becoming the basis for what a company was worth. To the point, fewer and fewer know how to value a company beyond what they or some one else can convince them what its worth based on their own expectations.
Even if JAGX gets their Ph 3 approved, I have asked the question of, what is their POTENTIAL MARKET CAP.. have yet to see an answer.
IE, how much of this product would they be expected to sell, at what possible price point, et al. A market cap of what was it, around $Million with the share price of 26 cents.. How much could that be expected to move up JUSTIFIABLY.
And for the record, do you really think the company is going to intentionally violate an SEC rule to try and hide how fast a reverse split is coming?
Seriously??
But will say, the more the share price dips, the lower the market cap drops? The more desirable the shares get.
The unfortunate part is, the cheaper the shares get, the more I suspect they will dilute to raise cash when a secondary happens. And I do expect one to happen after the 1-60.. Question is, how big will it be?? 10 Million shares?? Adding 2.5x the number of shares post the r/split?
Yep, the market has become a ponzi scheme and too few realize it...
You think the SEC will follow thru with any of the new requirements ? As long as their in the books ..they can say that they are making new regulations and helping retail investors. But they will never actually do anything about it. How about limiting offerings ? How about limiting reverse splits ? The market has become a friggin joke.
New rule requires companies to file public disclosure of split, at Noon ET at least 2 business days before.
If a company does not comply with the requirements of the New Rules and nonetheless proceeds with a reverse stock split, Nasdaq will halt trading in the company’s stock until all of the requirements in the New Rules are met and the dissemination of material news is complete.
Have we seen an 8-k, amendment to certificate or anything filed? Was the r/s even filed with the sec?
No 8-k 2 business days prior to so called "reverse split", what about the noon filing 1 day prior? These new rules not being followed? Or are they going to release results and cancel r/s 🤔🤔🤔🤔
Found this on Yahoo:
May 14th : Earnings call -> obvious message from Lisa that data is imminent
May 15th : Upload of the new investors presentation on their website
May 17th : Announcement reverse split
Following this timeline, what makes you think that P3 results will to be combined with the reverse split?
Following the previous question, what makes you think this is not (for once) a bullish reverse split?
Where do you read in the filing that they will raise the share count with or without approval? please enlighten me
Yes they are increasing the share count.The RS will come into effect on May 23rd,2024.They will increase the share count after the RS.With or without shareholder approval,as stated in the poxy.As with all of these RS's,as per companies,it is needed to stay on the Nasdaq.The common shareholder is not even in the equation.It's only about the insiders and their investors.Good luck and good trading.
Thanks, and I understand... I re-read the filing and actually they are not asking for more shares....
It is just for the incentive plan...
So no extra shares, reducing the float, taking us above the 5 dollar treshold for institutional buying... with still phase 3 data coming imminent ...
Looks extra bullish too me
Wish you the best! Been already in two RS here before don’t like it and good luck y’all I cash out with a lost my average was 38 cents
I don't agree. They filed a DEF14A, which we were expecting.
They are ONLY asking 760 k shares to be added to common stock after the reverse split.
This is +13% extra shares after the RS. Which is absolutely not that bad.
It seems they have some confidence in something, what would it be?
If CEO know they are any good they wouldn’t do RS just a free ATM sadly
folks need to remember, THEY are responsible for their OWN investment decisions.
YOU are playing in a world that is beyond YOUR CONTROL, and they owe you NOTHING
Statements like you just made can be seen as a THREAT in todays world.
YOU decided to be in this, the RISKS were there to be seen, YOU chose.
And in the baby biotech world, the PLAYBOOK is well understood as to what these baby bios
are LIKELY to be faced with, and DO as NEEDED to save themselves.
And what just happened is part of that playbook.
and unfortunately, many before, now and after will go thru the same type of events that just took place
cause THEY fail to consider the risks against the prospects they see themselves getting.
A friend of mine just making his first investments, I warned him not to go to the 'well' too many times.
People flipping for a couple pennies...that's all. What a disgrace this bitch of a CEO is. Wouldn't be surprised if someone takes revenge on this c***
YOU COULD BE RIGHT...I DO KNOW THERE WAS A LOTTA BIG BUYS COMING IN SUPPORTING JAGX TODAY...GLTA$$$$$$
Barcoding _-__-__-__-__-__ seen this before....
Ph3 data imminent.
R/s announcement was a share grab. R/s was known coming anyways.
Valuations still hasn't changed infact went higher.
That's for sure!
yeah, it's not just the OTC that will blind side you with a RS.
I mean, we've waited that much, might as well wait a couple of days more... Personally i'll wait till the first week of June (end of the ASCO conference), if not by then, i'm out with whatever i have left.
How long have we been waiting for Phase lll results ..? Might be in 2036..
Not if they release the results before then. Imo, there's a chance (not gonna bet on the % here) they do that in order to maximize the effect of the upcoming 1:60 r/s. But they could also not give a flying fart, and release the data in June or whenever, after the split, and long after the bears had their way with the stock.
Why ? This will tank until Thursday. R//S will probably take place at .10. No way out.
The amount of manipulation occurring in the L2 is astounding. It's disgusting
Thank God didn’t buy this garbage back never change big RS and big offering after. Free ATM
What a friggin bitch
Frankfurt Market is down -33.53% , expecting another drop once US market opens up. Stay safe everyone
Frankfurt market has best bid order in at .1098 EU , as I said before get ready for a huge correction today the markets are extremely pissed at the RS news. I will be waiting this could be pretty gnarly in the pre-market in our market.
WELL PEEPS...IDK HOW ITS GONNA GO THIS WEEK AND FURTHER ON BUT WANTED TO SAY GOOD LUCK AND PROSPERITY TO ALL!!
I see a big offering coming after R/S
I tried telling this board for a year and a half how Lisa worked and that she was a slim bucket with no regard for shareholders. I advised all of those who were here at that time to go look at the past 3 reverse splits not the size but that happened and what was said. You must go back in time to see the PRs that were released then to
Each time she would say “if we even need to do one” And they always have. What is so disheartening is If, as we all suspected, the Phase III is positive results and they put out additional information to go along with the positive results why do it at all.
Put out distribution information, put out partner information, put out revenue projections. All of that puts the stock at $5 minimum and if you doubt that you don’t know Jack shit about bio tech drugs. Also with those thing and a pretty much a guaranteed FDA approval after positive results this RS is for the benefit of Lisa and her butt buddies.
And don’t anyone dare say it’s for NASDAQ compliance, last month she PRed they gave her to early August for gaining a minimum BID of a dollar.
Read my posts since Jan of this year you will see she is a snake and always will be.
Correct, a smart short seller will stand down and let the r/split jack up the share price, and let expected PR help it.
THEN, with 9-12 months to go from the PR to a possible FDA decision day? And likely a dilution move to raise cash off
the elevated share price? Then hit it..
Course, their risk is that with the low share count, IF there is any positive surprises, they could get 'fried' trying to cover
into a rally.
I'm quoting myself here, since i can't edit my prev post and i've found an answer, if anyone cares:
WTF did this jail bird do??? LMAO
Tutes loading , expect to see $75.00+ share by year end.
Interesting the PR is dated yesterday but the split takes place next Thursday. Why not split on Monday? My GUESS is they are going to release a material PR, maybe Mon or Tues, likely Tues. Seems like a shakeout. Also I noticed the reason for the R/S is compliance and to get price up to attract more institutional buyers. Meme, favorable PR possibilities allows hopeful expectations. I have no info, just opinion.
Followers
|
134
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
6959
|
Created
|
12/01/15
|
Type
|
Free
|
Moderators SmellMyFinger |
Jaguar Health, Inc. $JAGX
Bringing Plant-based Medicines to Life™
Pharmaceutical Manufacturing
San Francisco, California
Jaguar Health’s organizational framework is designed to enable our product pipeline to reach the world’s interconnected marketplace, allowing for development and commercialization opportunities worldwide.
Products:
Mytesi Crofelemer 125mg delayed release tablets
Mytesi is FDA-approved for symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy
Mytesi has a novel mechanism of action that modulates chloride secretion in the gastrointestinal tract, reducing excessive chloride and accompanying water flow and relieving watery diarrhea.
Mytesi is not indicated for the treatment of infectious diarrhea. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (6%), bronchitis (4%), cough (4%), flatulence (3%), and increased bilirubin (3%).
Canalevia-CA1 Crofelemer delayed release tablets
Distributors listed:
https://www.canalevia.com/distributor-information
CANALEVIA-CA1 is conditionally approved for the treatment of chemotherapy-induced diarrhea (CID) in dogs.
Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-552.
CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal Law to use this product other than as directed in the labeling.
Pipeline: https://jaguar.health/pipeline/
About the Jaguar Health Family of Companies
Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, and bowel incontinence.
Jaguar Health https://jaguar.health/
Napo Pharmaceuticals https://napopharma.com/
Napo Therapeutics https://napotherapeutics.com/en/
https://www.magdalenabiosciences.com/
Magdalena is a joint venture formed by Jaguar Health and Filament Health. The company holds an exclusive license to Jaguar's proprietary library of approximately 2,300 highly characterized medicinal plants and 3,500 plant extracts for designated therapeutic indications.
Visit Jaguar on LinkedIn:
https://www.linkedin.com/company/jaguar-health/
Visit Jaguar on Instagram: https://www.instagram.com/jaguarhealthcommunity/
Visit Jaguar on X: https://twitter.com/Jaguar_Health
Phone: 415-371-8300
Contact: hello@jaguar.health
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |